Growth Metrics

Resmed (RMD) Gains from Investment Securities (2016 - 2025)

Resmed's Gains from Investment Securities history spans 16 years, with the latest figure at -$40.8 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 118.24% year-over-year to -$40.8 million; the TTM value through Dec 2025 reached -$185.2 million, down 410.45%, while the annual FY2025 figure was $18.1 million, 106.43% up from the prior year.
  • Gains from Investment Securities reached -$40.8 million in Q4 2025 per RMD's latest filing, down from $61.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $382.2 million in Q1 2022 to a low of -$179.8 million in Q2 2025.
  • Average Gains from Investment Securities over 5 years is $38.9 million, with a median of $19.0 million recorded in 2023.
  • The largest YoY upside for Gains from Investment Securities was 15805.66% in 2025 against a maximum downside of 42797.86% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $49.8 million in 2021, then soared by 116.59% to $107.9 million in 2022, then surged by 60.49% to $173.2 million in 2023, then grew by 29.3% to $224.0 million in 2024, then crashed by 118.24% to -$40.8 million in 2025.
  • Per Business Quant, the three most recent readings for RMD's Gains from Investment Securities are -$40.8 million (Q4 2025), $61.9 million (Q3 2025), and -$179.8 million (Q2 2025).